Upcoming Sartorius dividend
Change(%)
-48.95%
Decrease
Next payment 0.73€
Next payment date Apr 4, 2024
Last payment 1.43€
Last payment date Apr 3, 2023
00 D 00 H 00 M 00 S
Ex-Dividend: 4/2/24
Confirmed

Holders of shares in Sartorius will enjoy a dividend of 0,73 euros per share with a yield of 0.38% on April 4, 2024.

To receive a dividend of 0,73 euros from Sartorius, purchase the shares before April 2, 2024 and stay until the Record Date, April 3, 2024.

Sartorius made a dividend payment of 1.43 euros on April 3, 2023.

Sartorius AG, which is listed on the German and Austrian stock exchanges using the stock exchange indicator SRT, began paying dividends in 1999 and has been paying this interest continuously for more than twenty years.

The payment schedule is established by the stockholders' meeting, which approves the amount, being paid in a single installment between March and April, obtaining a yield of approximately 0.45%.

Payout Ratio Sartorius Dividends

Sartorius paid 3% of its net income in the last fiscal period as dividends.
Sartorius's earnings (3,312,100,096.00€) are sufficient to cover the dividend payment. This payment represents 3% of the total net profit of SRT.
Dividend payout ratio
Payout Ratio

Dividend calendar of Sartorius

These are the most important events of the Sartorius calendar in 2024:

Event Day
Last trading date April 1, 2024
Ex-Dividend (Ex-Date) April 2, 2024
Record date April 3, 2024
Date of payment April 4, 2024
Data confirmed by the company Sartorius (SRT).
Confirmed
Source
Historical annual dividend yields of Sartorius
Over the past 5 years, Sartorius has not consistently increased the annual dividend amount.
Increasing Dividends
Dividend yield
Dividend yield of Sartorius vs. the sector
Sartorius's dividend yield (0.37%) is below the sector average (1.87%).
Comparison with industry average
Sartorius's dividend yield is below the top 75% (0.52%) of the sector.
Evaluation with respect to competence.
Dividend yield history in Sartorius
Over the past 5 years, Sartorius's annual dividend income has fallen by more than 10%.
Dividend stability

Dividend history of Sartorius

In this table you can see the complete history:

YearEx-DividendAmountTotal
2023
03/30/2023
1.43 €
1.43 €
2022
03/28/2022
1.25 €
1.25 €
2021
03/29/2021
0.7 €
0.7 €
2020
06/29/2020
03/27/2020
0.35 €
0.7 €
1.05 €
2019
03/29/2019
0.61 €
0.61 €
2018
04/06/2018
0.5 €
0.5 €
2017
04/07/2017
0.45 €
0.45 €
2016
04/08/2016
0.375 €
0.375 €
2015
04/10/2015
0.265 €
0.265 €
2014
04/11/2014
0.25 €
0.25 €
2013
04/19/2013
0.235 €
0.235 €
2012
04/20/2012
0.2 €
0.2 €
2011
04/21/2011
0.15 €
0.15 €
2010
04/22/2010
0.073625 €
0.073625 €
2009
04/24/2009
0.1 €
0.1 €
2008
04/24/2008
0.165 €
0.165 €
2007
04/30/2007
0.155 €
0.155 €
2006
04/27/2006
0.125 €
0.125 €
2005
05/13/2005
0.1 €
0.1 €
2004
05/28/2004
0.06 €
0.06 €
2003
06/19/2003
0.06 €
0.06 €
2002
06/20/2002
0.06 €
0.06 €
2001
06/22/2001
0.06 €
0.06 €
2000
06/22/2000
0.06 €
0.06 €
Sartorius dividend capture strategy
Step 1: Buy Sartorius shares (SRT) one day before ex-dividend date
Date of purchase Apr 1, 2024
Next ex-dividend date Apr 2, 2024
Step 2: Sell Sartorius shares (SRT) when the price recovers.
Date of sale (estimated) N/A
Average price recovery N/A
Average return on cost N/A
The dividend capture strategy is based on historical Sartorius data. Past performance is no guarantee of future results.

Information about Sartorius

Full name Sartorius Aktiengesellschaft
Ticker SRT
Sector Health Care
Industry Medical Instruments & Supplies
Market Capitalization 14.84B €
ISIN DE0007165607
Number of Employees 15,942
Description of the company

Sartorius AG, an international company based in Germany, manufactures equipment and products for pharmaceutical laboratories.

Along the way, it has made several acquisitions as part of its growth strategy, including B. Braun Biotech International (BBI), Viva Science, Omnimark Instrument Corporation, Stedim SA, Toha Plast GmbH, Wave Biotech AG, the liquid handling business of Biohit Laboratory, kSep Systems, Essen BioScience, Xell AG and signed a co-development agreement with Nova Biomedical.

The company helps biotech engineers and scientists develop drugs to treat previously incurable diseases such as cancer and dementia by offering instruments, laboratory services, consumables and chemicals, water purification systems, fermentation solutions, fluid management, as well as software and training.

Its product portfolio includes Bioreactors, Fermenters, Cell Culture Media, Cell Sorting and Recovery, Flow Cytometry, Fluid Management, Industrial Microbiology, Fleet Management and Laboratory Data Software, Laboratory Filtration and Purification, Live Cell Imaging and Analysis, Pipetting, Process Chromatography, Process Filtration, Protein Analysis, among others.

Its services have mainly scientific applications, collaborating with biopharmaceutical manufacturing, Life science research, Infectious disease study, Regenerative medicine, Vaccine development, Cell and gene therapy, Pharmaceutical compliant weighing, Virus quantification, Food drinking, Medical device quality control, Oncology, Immunology, Neuroscience, Antibody discovery, Small molecule discovery, Virology and quality control industries, Food Beverage, Medical Device Quality Control, Oncology, Immunology, Neuroscience, Antibody Discovery, Small Molecule Discovery, Virology and Quality Control and Applied Industries, accelerating time-to-market with cost-saving production platforms.

Frequently asked questions about Sartorius dividends

Sartorius pays dividends on a Anual basis.

Sartorius is listed on the Bolsa de Fráncfort and is part of the DAX40.

Sartorius has the Ticker or stock code SRT.

The CEO of Sartorius in 2024 is Dr. Joachim Kreuzburg.

Sartorius does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.

Sartorius ForumCheck the latest comments and participate in the live chat on Sartorius stocks (SRT).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments